List of Contents

Olympus Introduces Innovative Surgical Tool for Hemostatic Cutting and Vessel Sealing


Published: 22 Oct 2025

Author: Precedence Research

Share : linkedin twitter facebook

In Tokyo, Japan, Olympus Corporation (Olympus) has announced THUNDERBEATtm II, the new model in its popular line of hybrid energy surgical instruments, aimed at enhancing patient outcomes and surgical innovation. THUNDERBEAT II is designed to redefine the expectations of precision, speed, and safety in laparoscopic and open surgery, offering faster and more hemostatic dissection, along with higher vessel sealing that is more precise and safer. The product was commercially launched in Europe in October 2025 and later in Japan and other international markets.

Olympus

Olympus has developed a new hybrid energy platform that builds on the excellent heritage of the original THUNDERBEAT series and incorporates the strengths of new bipolar and ultrasonic energy into a single system. The THUNDERBEAT II second generation has taken a big step ahead in providing sophisticated design, improved ergonomics, and enhanced power control. This enables the surgeon to perform intricate tissue surgeries with greater precision and confidence. With a clear emphasis on thermal diffusion reduction and optimal tissue integrity, THUNDERBEAT II introduces several innovations that enhance surgical safety and efficiency in the operating room.

The introduction of THUNDERBEAT II into the market aligns with its overall objective of promoting minimally invasive surgery (MIS) through new energy solutions. As surgical operations continually improve, the demand for smart tools capable of performing multiple tasks without sacrificing accuracy is higher than ever before. THUNDERBEAT II will also enable Olympus to further establish itself as a leader in the field of hybrid energy platforms. In terms of the market, the launch of THUNDERBEAT II will further enhance the competitiveness of Olympus in the global surgical energy equipment market.

Executive’s Statement:

Phil Roy, Deputy General Manager and Leader of Global Business Unit, Surgical Devices, Olympus:

Having developed to assist surgeons in performing complicated surgical operations, THUNDERBEAT II reflects the investment that Olympus has in developing hybrid energy technology. We are thrilled to add it to our surgical energy line because it is aimed at meeting the demands of surgeons and increasing the clinical outcome. Thunderbeat II was created in direct correlation to what surgeons have requested: speed, precision, and reliability. Every component of THUNDERBEAT II was created in direct response.

Latest News